Two Yale Department of Psychiatry researchers are among the recipients of the American College of Neuropsychopharmacology (ACNP) 2025 Travel Award.
Anahita Bassir Nia, MD, assistant professor of psychiatry, and Rachel Bandler, MD, PhD, a resident in the Neuroscience Research Training Program, will receive registration for themselves and a guest to attend the ACNP’s annual meeting, to be held Jan. 12-15, 2026 in Nassau, Bahamas.
Other benefits include the opportunity to present a poster abstract and an ANCP member mentor for the annual meeting, as well as airfare, ground transportation, and accommodations in the Bahamas.
The ACNP annually selects young scientists in the field of neuropsychopharmacology for the travel award program, which offers an opportunity to attend a program in clinical and basic research on brain-behavior-drug interactions; become aware of the most recent, and often unpublished, advances in psychopharmacology; and meet and interact with internationally distinguished researchers and scientists.
Bassir Nia is a researcher at the National Center for PTSD (NCPTSD), Division of Clinical Neuroscience, VA Connecticut Health Care System. At her Yale Adversity, Brain, and Novel Therapeutics (ABN) Lab, she conducts translational research aimed at developing novel treatments for stress-related psychiatric disorders, including posttraumatic stress disorder and substance use disorders. Her primary areas of focus are the therapeutic potential of cannabinoids and psychedelics.
Bandler applies basic neuroscience research tools to better understand and treat neuropsychiatric illnesses. She is particularly interested in disorders with a developmental origin, including autism and schizophrenia.